IGSF10 Growth Factor for Bone Regeneration and Inflammation Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone tissue regeneration methods using growth factors like BMPs are often associated with adverse reactions such as swelling and ectopic mineralization, and they do not effectively address bone loss caused by inflammation in diseases like periodontitis.
Innovation Solution
The use of IGSF10 in combination with other growth factors such as BMP, PDGF, EMP, and amelogenin for bone tissue regeneration, which can reduce the effective concentration of other growth factors and minimize adverse reactions, while also promoting bone regeneration and inhibiting inflammatory bone loss.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional growth factors like BMPs are used for bone tissue regeneration, then bone regeneration is promoted, but adverse reactions such as swelling and ectopic mineralization occur
Solution Approach 1:
The patent introduces IGSF10 as an intermediary growth factor that mediates bone regeneration. IGSF10 acts as a synergistic agent that enhances the osteogenic effects of BMPs while reducing their harmful side effects. The combination of IGSF10 and BMPs creates a balanced biological response that promotes bone formation without causing excessive swelling or ectopic mineralization, thus resolving the contradiction between effective bone regeneration and adverse reactions.
Solution Approach 2:
The patent modifies the concentration and delivery parameters of growth factors by combining IGSF10 with BMPs in specific ratios. This parameter optimization allows for reduced doses of BMPs while maintaining effective bone regeneration. The synergistic interaction between IGSF10 and BMPs changes the biological parameters of the growth factor system, achieving better safety-profile with maintained efficacy.
2Reliability
If traditional growth factors are used for bone regeneration, then bone tissue repair is promoted, but they do not effectively address bone loss caused by inflammation
Solution Approach 1:
The patent positions IGSF10 as a universal growth factor that performs multiple functions: it promotes bone regeneration, enhances the effects of other growth factors like BMPs and PDGF, and specifically addresses bone loss in inflammatory conditions such as periodontitis. This multi-functionality allows a single growth factor to tackle diverse bone repair scenarios, including both acute injuries and chronic inflammatory bone loss, thereby improving adaptability while maintaining bone repair effectiveness.
Data Source
AI summary
A bone tissue regeneration product, a method for preparing the bone tissue regeneration product and, and a method for repairing a bone defect. The new use of IGSF10 of the present disclosure can reduce the effective concentration of BMP without obvious adverse reactions, thereby exploring a method to promote bone tissue regeneration and providing new ideas for the treatment of bone defects. The present disclosure is capable of promoting non-bone related cells to produce bones; the method of the present disclosure is also capable of inhibiting the bone loss in inflammatory environments.